Print

Deep Genomic Analysis Identifies a Micro RNA Opponent for Ovarian Cancer, MD Anderson Cancer Center Study  
2/12/2013 7:02:01 AM

Researchers employed an extensive analysis of genomic information to identify a new, high-risk cohort of ovarian cancer patients, characterize their tumors, find a potential treatment and test it in mouse models of the disease. The exhaustive analysis that led to micro RNA 506 (miR-506) as a potential therapeutic candidate for advanced or metastatic ovarian cancer is the cover article in the Feb. 11 edition of Cancer Cell.
//-->